Jennifer Adjemian

10.1k citations

65 papers · 4.9k indexed · 5 hit papers · h-index 32

Epidemiology top 1%
Infectious Diseases top 0.5%
Small Animals top 0.2%
Oncology top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: D. Rebecca Prevots Kenneth N. Olivier Amy E. Seitz Steven M. Holland Kathleen P. Hartnett Aaron Kite-Powell Jourdan DeVies Adi V. Gundlapalli
Topics: Mycobacterium research and diagnosis (22 papers)Tuberculosis Research and Epidemiology (15 papers)Infectious Diseases and Mycology (10 papers)
Cited by: Applied Microbiology and Biotechnology Small Animals Infectious Diseases
Journals: New England Journal of Medicine PLoS ONE American Journal of Respiratory and Critical Care Medicine
Partner nations: United States United Kingdom Canada

In The Last Decade

Jennifer Adjemian

63 papers receiving 4.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of the COVID-19 Pandemic on Emergency Department Visits — United States, January 1, 2019–May 30, 2020

2020 779 citations Kathleen P. Hartnett, Aaron Kite-Powell et al. MMWR Morbidity and Mortality Weekly Report profile →
Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiaries

2012 482 citations Jennifer Adjemian, Kenneth N. Olivier et al. American Journal of Respiratory and Critical Care Medicine profile →
Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12–25 Years Before and During the COVID-19 Pandemic — United States, January 2019–May 2021

2021 381 citations Lakshmi Radhakrishnan, Michael Sheppard et al. MMWR Morbidity and Mortality Weekly Report profile →
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

2018 377 citations Sameer S. Kadri, Jennifer Adjemian et al. profile →
Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008–2015

2019 189 citations Jennifer Adjemian et al. Annals of the American Thoracic Society profile →

Peers

Countries citing papers authored by Jennifer Adjemian

Since Specialization

Citations

This map shows the geographic impact of Jennifer Adjemian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Adjemian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Adjemian more than expected).

Fields of papers citing papers by Jennifer Adjemian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Adjemian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Adjemian. The network helps show where Jennifer Adjemian may publish in the future.

Co-authorship network of co-authors of Jennifer Adjemian

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Adjemian. A scholar is included among the top collaborators of Jennifer Adjemian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Adjemian. Jennifer Adjemian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Who Gets Sick From COVID-19? Sociodemographic Correlates of Severe Adult Health Outcomes During Alpha- and Delta-Variant Predominant Periods: September 2020–November 2021 2023 ·The Journal of Infectious Diseases ·Stanley C. Wei,(unknown),(unknown),Kristie E.N. Clarke,Miriam E. Van Dyke,Jennifer Adjemian,Farida Ahmad,Tina J. Benoit,(unknown),Adi V. Gundlapalli,Aron J. Hall,Fiona P. Havers,S. Jane Henley,Charity Hilton,(unknown),Jean D. Opsomer,Thị Thu Hương Phạm,Matthew J. Stuckey,Christopher A. Taylor,Jefferson M. Jones	5
2	COVID-19 pandemic–associated changes in overall emergency department visits by age group, race, and ethnicity — United States, January 2019–April 2022 2023 ·The American Journal of Emergency Medicine ·Amanda R. Smith,Jourdan DeVies,Kelly Carey,Michael Sheppard,Lakshmi Radhakrishnan,Rashid Njai,Umed A. Ajani,Karl Soetebier,Kathleen P. Hartnett,Jennifer Adjemian	9
3	Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022 2022 ·MMWR Morbidity and Mortality Weekly Report ·Jennifer L. Kriss,Peter Boersma,(unknown),(unknown),Jennifer Adjemian,Nathaniel Smith,Rosalind J. Carter,Kathrine R. Tan,(unknown),(unknown),(unknown),(unknown),(unknown),Adi V. Gundlapalli	31
4	Impact of the COVID-19 Vaccination Program on case incidence, emergency department visits, and hospital admissions among children aged 5–17 Years during the Delta and Omicron Periods—United States, December 2020 to April 2022 2022 ·PLoS ONE ·(unknown),Michael Sheppard,Grace E. Marx,Ryan E. Wiegand,Ruth Link‐Gelles,Alison M. Binder,(unknown),B. Casey Lyons,Sohyun Park,Hannah E. Fast,(unknown),Roseric Azondékon,(unknown),Jennifer Adjemian,Kamil E. Barbour	3
5	Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments 2021 ·Vaccine ·Lakshmi Radhakrishnan,Zachary Stein,Jourdan DeVies,Amanda R. Smith,Michael Sheppard,Kathleen P. Hartnett,Aaron Kite-Powell,Jennifer Adjemian,Loren Rodgers	2
6	Impact of the COVID-19 Pandemic on Emergency Department Visits — United States, January 1, 2019–May 30, 2020breakdown → 2020 ·MMWR Morbidity and Mortality Weekly Report ·Kathleen P. Hartnett,Aaron Kite-Powell,Jourdan DeVies,Michael Coletta,Tegan K. Boehmer,Jennifer Adjemian,Adi V. Gundlapalli,(unknown)	779
7	Ecological Analyses of Mycobacteria in Showerhead Biofilms and Their Relevance to Human Health 2018 ·mBio ·Matthew J. Gebert,Manuel Delgado‐Baquerizo,Angela Oliverio,Tara M. Webster,Lauren M. Nichols,Jennifer R. Honda,Edward D. Chan,Jennifer Adjemian,Robert R. Dunn,Noah Fierer	107
8	2398. Utilization Practices of Ceftazidime–Avibactam at Academic Medical Centers in the United States 2018 ·Open Forum Infectious Diseases ·Jeffrey R. Strich,Emily Ricotta,Yi Ling Lai,Samuel F. Hohmann,(unknown),Chanu Rhee,Michael Klompas,Tara N. Palmore,John H. Powers,John P. Dekker,Jennifer Adjemian,Robert L. Danner,Sameer S. Kadri	1
9	Serological Survey for Antibodies to Mosquito-Borne Bunyaviruses Among US National Park Service and US Forest Service Employees 2016 ·Vector-Borne and Zoonotic Diseases ·Olga Kosoy,Ingrid B. Rabe,Aimee Geissler,Jennifer Adjemian,Amanda J. Panella,Janeen Laven,Alison Jane Basile,Jason O. Velez,Kevin Griffith,David Wong,Marc Fischer,Robert S. Lanciotti	20
10	Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease 2015 ·American Journal of Respiratory and Critical Care Medicine ·David E. Griffith,Jennifer Adjemian,Barbara A. Brown‐Elliott,Julie V. Philley,D. Rebecca Prevots,(unknown),Kenneth N. Olivier,Richard J. Wallace	53
11	The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States 2015 ·Annals of the American Thoracic Society ·Sara Strollo,Jennifer Adjemian,Michael K. Adjemian,D. Rebecca Prevots	113
12	Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study 2014 ·European Respiratory Journal ·Dirk Wagner,Jakko van Ingen,Jennifer Adjemian,Christoph Lange,D. Rebecca Prevots,David E. Griffith,Jack R. Gallagher,Renu Gupta,Charles Haworth	10
13	Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United States 2014 ·European Respiratory Journal ·Jakko van Ingen,Jennifer Adjemian,Kozo Morimoto,Dirk Wagner,Christoph Lange,Charles Haworth,Jack R. Gallagher,D. Rebecca Prevots,Renu Gupta,David E. Griffith	2
14	Nontuberculous Mycobacteria among Patients with Cystic Fibrosis in the United States. Screening Practices and Environmental Risk 2014 ·American Journal of Respiratory and Critical Care Medicine ·Jennifer Adjemian,Kenneth N. Olivier,D. Rebecca Prevots	103
15	Environmental Risks for Nontuberculous Mycobacteria. Individual Exposures and Climatic Factors in the Cystic Fibrosis Population 2014 ·Annals of the American Thoracic Society ·D. Rebecca Prevots,Jennifer Adjemian,(unknown),Michael R. Knowles,Kenneth N. Olivier	60
16	Lack of Adherence to Evidence-based Treatment Guidelines for Nontuberculous Mycobacterial Lung Disease 2014 ·Annals of the American Thoracic Society ·Jennifer Adjemian,D. Rebecca Prevots,Jack R. Gallagher,(unknown),Renu Gupta,David E. Griffith	96
17	Epidemiology of Nontuberculous Mycobacterial Infections and Associated Chronic Macrolide Use among Persons with Cystic Fibrosis 2013 ·American Journal of Respiratory and Critical Care Medicine ·Alison M. Binder,Jennifer Adjemian,Kenneth N. Olivier,D. Rebecca Prevots	100
18	Spatial Clusters of Nontuberculous Mycobacterial Lung Disease in the United States 2012 ·American Journal of Respiratory and Critical Care Medicine ·Jennifer Adjemian,Kenneth N. Olivier,Amy E. Seitz,Joseph O. Falkinham,Steven M. Holland,D. Rebecca Prevots	162
19	Prevalence of Nontuberculous Mycobacterial Lung Disease in U.S. Medicare Beneficiariesbreakdown → 2012 ·American Journal of Respiratory and Critical Care Medicine ·Jennifer Adjemian,Kenneth N. Olivier,Amy E. Seitz,Steven M. Holland,D. Rebecca Prevots	482
20	Predicting the Emergence of Tick-Borne Infections Based on Climatic Changes in Korea 2008 ·Vector-Borne and Zoonotic Diseases ·Joon-Seok Chae,Jennifer Adjemian,Heung-Chul Kim,Sungjin Ko,Terry A. Klein,Janet E. Foley	18

About Jennifer Adjemian

Jennifer Adjemian is a scholar working on Applied Microbiology and Biotechnology, Microbiology and Infectious Diseases, having authored 65 papers that have together received 4.9k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (22 papers), Tuberculosis Research and Epidemiology (15 papers) and Infectious Diseases and Mycology (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (343 citations), Small Animals (812 citations) and Infectious Diseases (1.8k citations). Jennifer Adjemian has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include D. Rebecca Prevots, Kenneth N. Olivier, Amy E. Seitz, Steven M. Holland, Kathleen P. Hartnett, Aaron Kite-Powell, Jourdan DeVies, Adi V. Gundlapalli, Michael Coletta and Tegan K. Boehmer. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact